Literature DB >> 9630120

Toward consistency in cost-utility analyses: using national measures to create condition-specific values.

M R Gold1, P Franks, K I McCoy, D G Fryback.   

Abstract

OBJECTIVES: The authors developed an "off-the-shelf" source of health-related quality of life (HRQL) scores for cost-effectiveness analysts unable to collect primary data.
METHODS: The authors derived and conducted preliminary validation on a set of health-related quality of life scores for chronic conditions using nationally representative data from the National Health Interview Survey (NHIS) and the Healthy People 2000 Years of Healthy Life measure developed to monitor the health (longevity and health-related quality of life) of Americans during this decade. The measure comprises two domains, role function and self-rated health, and is scaled from 0 (death) to 1 (best health state). Health-related quality of life scores for chronic conditions were calculated using the Years of Healthy Life scores associated with chronic conditions reported in the 1987-1992 National Health Interview Survey. Preliminary validation was examined by comparing the health-related quality of life scores with those obtained in two other studies.
RESULTS: Tables provide health-related quality of life scores for persons with and without conditions. The scores had reasonable face validity, ranging from 0.87 for allergic rhinitis to 0.27 for hemiplegia. Correlations of the health-related quality of life condition weight scores with those from two other studies were 0.78 and 0.86.
CONCLUSIONS: These condition weights may prove useful to investigators conducting cost-effectiveness analyses using secondary data, where community ratings of health-related quality of life for chronic conditions are required. Use of a standard set of health-related quality of life weights gathered from a national sample can enhance the comparability of cost-effectiveness analyses. Improvements in national data collection techniques, with empirical gathering of preferences, will further strengthen this measure.

Entities:  

Mesh:

Year:  1998        PMID: 9630120     DOI: 10.1097/00005650-199806000-00002

Source DB:  PubMed          Journal:  Med Care        ISSN: 0025-7079            Impact factor:   2.983


  135 in total

Review 1.  Methodological hurdles in conducting pharmacoeconomic analyses.

Authors:  J D Rizzo; N R Powe
Journal:  Pharmacoeconomics       Date:  1999-04       Impact factor: 4.981

2.  The economic effect of screening orthopedic surgery patients preoperatively for methicillin-resistant Staphylococcus aureus.

Authors:  Bruce Y Lee; Ann E Wiringa; Rachel R Bailey; Vishal Goyal; Becky Tsui; G Jonathan Lewis; Robert R Muder; Lee H Harrison; Lee M Harrison
Journal:  Infect Control Hosp Epidemiol       Date:  2010-11       Impact factor: 3.254

3.  Economic value of dispensing home-based preoperative chlorhexidine bathing cloths to prevent surgical site infection.

Authors:  Rachel R Bailey; Dianna R Stuckey; Bryan A Norman; Andrew P Duggan; Kristina M Bacon; Diana L Connor; Ingi Lee; Robert R Muder; Bruce Y Lee
Journal:  Infect Control Hosp Epidemiol       Date:  2011-05       Impact factor: 3.254

4.  Managing mesh exposure following vaginal prolapse repair: a decision analysis comparing conservative versus surgical treatment.

Authors:  Laura C Skoczylas; Jonathan P Shepherd; Kenneth J Smith; Jerry L Lowder
Journal:  Int Urogynecol J       Date:  2012-06-30       Impact factor: 2.894

5.  Comment on Silber et al.: Investing in postadmission survival—a “failure-to-rescue” U.S. population health.

Authors:  Amber E Barnato
Journal:  Health Serv Res       Date:  2010-12       Impact factor: 3.402

6.  Screening cardiac surgery patients for MRSA: an economic computer model.

Authors:  Bruce Y Lee; Ann E Wiringa; Rachel R Bailey; Vishal Goyal; G Jonathan Lewis; Becky Y K Tsui; Kenneth J Smith; Robert R Muder
Journal:  Am J Manag Care       Date:  2010-07-01       Impact factor: 2.229

7.  Cost effectiveness of a program to promote screening for cervical cancer in the Vietnamese-American population.

Authors:  John F Scoggins; Scott D Ramsey; J Carey Jackson; Victoria M Taylor
Journal:  Asian Pac J Cancer Prev       Date:  2010

8.  Preference-Based EQ-5D index scores for chronic conditions in the United States.

Authors:  Patrick W Sullivan; Vahram Ghushchyan
Journal:  Med Decis Making       Date:  2006 Jul-Aug       Impact factor: 2.583

9.  Mapping the EQ-5D index from the SF-12: US general population preferences in a nationally representative sample.

Authors:  Patrick W Sullivan; Vahram Ghushchyan
Journal:  Med Decis Making       Date:  2006 Jul-Aug       Impact factor: 2.583

10.  Cost-effectiveness of Canakinumab for Prevention of Recurrent Cardiovascular Events.

Authors:  Thomas S G Sehested; Jenny Bjerre; Seul Ku; Andrew Chang; Alison Jahansouz; Douglas K Owens; Mark A Hlatky; Jeremy D Goldhaber-Fiebert
Journal:  JAMA Cardiol       Date:  2019-02-01       Impact factor: 14.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.